For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
Head and neck squamous cell carcinoma (HNSCC) remains a globally prevalent malignancy with high morbidity and mortality. Despite therapeutic advances, patient outcomes are hindered by tumor ...